DelveInsight’s Advanced Cervical Cancer pipeline report depicts a robust space with 70+ active players working to develop 75+ ...
18h
GlobalData on MSNImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment comboThe trial is anticipated to enrol 462 subjects and aims to confirm the safety and efficacy of the combination.
An estimated 42 million people in India suffer from thyroid problems, an autoimmune condition that has grown very common. The most frequent cause is thought to be iodine deficiency brought on by ...
Among patients of child-bearing age, the crucial topic of whether cervical cancer impacts fertility frequently comes up ...
A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
Baird Medical Investment Holdings Ltd. ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, today announced its successful participation in the 2025 Microcap Conference ...
Patients diagnosed with more advanced breast cancer are more likely to have cardiovascular disease, a large study suggests.
Paolo Tarantino, MD, PhD, discusses the approval of the oral therapy elacestrant for patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer with ESR1 mutations.
6h
Verywell Health on MSNNavigating Care Through Every Phase of Metastatic Breast CancerIf you have metastatic breast cancer, you may need help from loved ones and your medical team along the way. Here’s how to ...
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
World Cancer Day, observed every year on February 4, raises awareness about cancer prevention, detection, and treatment. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results